Skip to main content
. 2017 Feb 6;6(3):e1288331. doi: 10.1080/2162402X.2017.1288331

Figure 2.

Figure 2.

Prognostic impact of (A) combined total CD8+/PD-1 and (B) combined CD8+/PD-L1 expression on cumulative incidence of local recurrence and disease-free survival, as indicated. Analysis was based on the dichotomized total score in patient tumor samples (cut-off according to median value of total score).